Αποτελέσματα Αναζήτησης
1 Απρ 2020 · Cancer immunotherapy is an innovative treatment for tumors today. In various experiments and clinical studies, it has been found that immunotherapy does have incomparable advantages over traditional anti-tumor therapy, which can prolong progression-free survival (PFS) and overall survival (OS).
- Conditioning Neoadjuvant Therapies for Improved Immunotherapy of Cancer
The emerging concept of conventional cancer therapies...
- Sci
Infectious complications, predominantly pulmonary and...
- Natural Killer Cells Unleashed
1. Introduction. Natural killer (NK) cells were originally...
- Conditioning Neoadjuvant Therapies for Improved Immunotherapy of Cancer
Immunotherapy undeniably plays an important part in cancer treatment—contributing to a future that transforms cancer from an acute diagnosis to a chronic manageable disease. But no anticancer treatment comes without risk.
1 Απρ 2020 · In this review article, we highlight the current standards of care in cancer immunotherapy, with a strong focus on immune checkpoint inhibitors (ici s), their limitations and pitfalls, and promising novel approaches.
24 Οκτ 2022 · Overall, with the increasing rate of the aging population, immunotherapy offers a promising approach in the overall treatment of cancer, as a stand-alone treatment or in combination with other conventional cancer treatments.
17 Αυγ 2022 · Harnessing the immune system to treat cancer has led to a large growth in the number of novel immunotherapeutic strategies, including immune checkpoint inhibition, chimeric antigen receptor T-cell therapy and cancer vaccination.
Immunotherapy has become one of the most widely used interventions for treating patients with cancer and continues to be a fertile area of research with new targets, drug classes, and combination therapies being discovered regularly.
This review gives an overview of recent developments in immunotherapy and indicates a new direction of tumor treatment through analyzing the pros and cons of immunotherapy coupled with keeping a close watch on the development trend of the immunotherapy future.
